Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study Article

sustainable development goals

authors

publication date

  • July 1, 2017

webpage

published in

keywords

  • Gonadotropin-releasing hormone antagonist
  • heavy menstrual bleeding
  • leiomyoma
  • nonpeptide
  • oral

start page

  • 152

end page

  • +

volume

  • 108

issue

  • 1